Tržní kapitalizace společnosti Zynex

Jaká je hodnota metriky Tržní kapitalizace společnosti Zynex?

Hodnota metriky Tržní kapitalizace společnosti Zynex, Inc. je $535.32M

Jaká je definice metriky Tržní kapitalizace?



Tržní kapitalizace (Market cap) je tržní hodnotou vydaných akcií obchodované společnosti a rovná se ceně akcií v daném čase vynásobené počtem kusů vydaných akcií .

As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.

Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.

The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.

Tržní kapitalizace společností v sektoru Health Care sektor na XETRA ve srovnání se společností Zynex

Čemu se věnuje společnost Zynex?

Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. It offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation (NMES) device; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. The company also supplies electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products; and distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, and LSO Back Braces for lumbar support. In addition, it offers CM-1500, a blood volume monitor device for monitoring central blood volume for use in operating and recovery rooms to detect blood loss during surgery and internal bleeding during recovery. The company provides its products for use in pain management and control; and stroke and spinal cord injury rehabilitation. Zynex, Inc. sells its products through direct sales force primarily in the United States. The company was founded in 1996 and is headquartered in Englewood, Colorado.

Firmy s metrikou tržní kapitalizace podobnou společnosti Zynex



  • Hodnota metriky Tržní kapitalizace společnosti Hunting PLC je $534.61M
  • Hodnota metriky Tržní kapitalizace společnosti Bank of Cyprus Public je $534.62M
  • Hodnota metriky Tržní kapitalizace společnosti Vishay Precision Inc je $534.80M
  • Hodnota metriky Tržní kapitalizace společnosti ICRA je $534.81M
  • Hodnota metriky Tržní kapitalizace společnosti BioXcel Therapeutics Inc je $535.24M
  • Hodnota metriky Tržní kapitalizace společnosti Endeavour Silver je $535.25M
  • Hodnota metriky Tržní kapitalizace společnosti Zynex je $535.32M
  • Hodnota metriky Tržní kapitalizace společnosti Capstone Turbine je $535.52M
  • Hodnota metriky Tržní kapitalizace společnosti Jamna Auto Industries je $535.69M
  • Hodnota metriky Tržní kapitalizace společnosti Capital City Bank je $536.05M
  • Hodnota metriky Tržní kapitalizace společnosti Seres Therapeutics Inc je $536.39M
  • Hodnota metriky Tržní kapitalizace společnosti Tervita je $536.40M
  • Hodnota metriky Tržní kapitalizace společnosti Einhell Germany AG je $536.57M